1,129 results on '"Heath, Paul T."'
Search Results
2. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
3. The COVID19 Pandemic has Changed Women's Experiences of Pregnancy in the UK
4. Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study
5. Long-term impact of serious neonatal bacterial infections on neurodevelopment
6. Update on Vaccines in Antenatal Care
7. Update on Vaccines in Antenatal Care
8. Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
9. Immunisation in children with cancer
10. Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
11. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
12. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden
13. An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants.
14. COVID-19 in Children and COVID-19 Vaccines
15. RSV Vaccines and Monoclonal Antibodies in Development
16. GBS and CMV Vaccines in Pipeline Development
17. Experiences of pregnant women and healthcare professionals of participating in a digital antenatal CMV education intervention
18. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
19. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
20. Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
21. Incidence of Group B Streptococcus Disease in Infants in China: An Updated Systematic Review and Meta-analysis
22. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
23. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
24. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
25. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK
26. THE PREDICTIVE ROLE OF SYMPTOMS IN COVID-19 DIAGNOSTIC MODELS – A LONGITUDINAL INSIGHT
27. Safety and Immunogenicity of an Acellular Pertussis Vaccine Containing Genetically-Detoxified Pertussis Toxin Administered to Pregnant Women Living with and Without HIV and Their New-Borns: A Randomised Controlled Trial in Uganda
28. Systematic Review and Meta-Analyses of Incidence for Group B Streptococcus Disease in Infants and Antimicrobial Resistance, China
29. SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia
30. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries
31. Changing knowledge, attitudes and behaviours towards cytomegalovirus in pregnancy through film-based antenatal education: a feasibility randomised controlled trial of a digital educational intervention
32. A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants
33. Serocorrelates of protection against infant group B streptococcus disease
34. Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: a prospective surveillance study
35. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial
36. Risk of Invasive Meningococcal Disease in Preterm Infants.
37. Propositive follow‐up: Long‐term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV
38. 2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial
39. Vaccination in pregnancy in specific circumstances
40. Contributors
41. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
42. New Vaccines in Pipeline Development
43. Respiratory Syncytial Virus Vaccination During Pregnancy and Effects in Infants
44. Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
45. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis
46. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort
47. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial
48. Propositive follow‐up: Long‐term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
49. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
50. Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.